Scott Michael Habig - Net Worth and Insider Trading
Scott Michael Habig Net Worth
The estimated net worth of Scott Michael Habig is at least $4 Million dollars as of 2024-11-29. Scott Michael Habig is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc and owns about 456,338 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $4 Million. Details can be seen in Scott Michael Habig's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Michael Habig has not made any transactions after 2024-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Michael Habig
Scott Michael Habig Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Michael Habig owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Scott Michael Habig’s form 4 insider trades.
Insider Ownership Summary of Scott Michael Habig
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-08-06 | Chief Commercial Officer |
Scott Michael Habig Latest Holdings Summary
Scott Michael Habig currently owns a total of 1 stock. Scott Michael Habig owns 456,338 shares of Aurinia Pharmaceuticals Inc (AUPH) as of August 6, 2024, with a value of $4 Million.
Latest Holdings of Scott Michael Habig
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc | 2024-08-06 | 456,338 | 8.85 | 4,038,591 |
Holding Weightings of Scott Michael Habig
Scott Michael Habig Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Michael Habig has made a total of 4 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 18,249 shares on August 6, 2024, which brought Scott Michael Habig around $96,902.
Insider Trading History of Scott Michael Habig
- 1
Scott Michael Habig Trading Performance
GuruFocus tracks the stock performance after each of Scott Michael Habig's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Michael Habig is 65.61%. GuruFocus also compares Scott Michael Habig's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Michael Habig within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Michael Habig's insider trading performs compared to the benchmark.
Performance of Scott Michael Habig
Scott Michael Habig Ownership Network
Scott Michael Habig Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Scott Michael Habig is the Chief Commercial Officer of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include director & Chief Executive Officer Peter Greenleaf , Chief Financial Officer Joseph M Miller , and Ex VP & Intern'l Operations Matthew Maxwell Donley .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Scott Michael Habig made 3 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 51,893. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 30,076 shares made by Volker Knappertz , a net sale of 126,981 shares made by Peter Greenleaf , and a net sale of 57,745 shares made by Stephen P. Robertson .
In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 9,798 shares. During the past 18 months, 373,927 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 373,927 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Scott Michael Habig Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Michael Habig. You might contact Scott Michael Habig via mailing address: #1203-4464 Markham Street, Victoria A1 V8z7x8.